iCo Therapeutics Inc. is a biotechnology company based in San Francisco, CA, that focuses on the development of drugs through redosing or reformulating existing medications for new or expanded labels, aiming to improve the health of individuals and contribute to the advancement of medical treatments worldwide.
With a strong management team and a portfolio of carefully selected and optimized drugs, iCo Therapeutics reduces development risk by targeting drugs that are off-patent, currently approved, or near commercialization, benefiting from the established clinical testing, manufacturing processes, and mechanisms of action. Through a partnership with Canadian Pharmacy, iCo Therapeutics enhances patient outcomes by spreading information about newly available doses and expanded uses of medications, while increasing the visibility of their groundbreaking work.
Generated from the website